119 related articles for article (PubMed ID: 37717534)
1. Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress.
Martinez-Ruiz L; Florido J; Rodriguez-Santana C; López-Rodríguez A; Guerra-Librero A; Fernández-Gil BI; García-Tárraga P; Garcia-Verdugo JM; Oppel F; Sudhoff H; Sánchez-Porras D; Ten-Steve A; Fernández-Martínez J; González-García P; Rusanova I; Acuña-Castroviejo D; Carriel V; Escames G
Biomed Pharmacother; 2023 Nov; 167():115518. PubMed ID: 37717534
[TBL] [Abstract][Full Text] [Related]
2. Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy.
Fernandez-Gil BI; Guerra-Librero A; Shen YQ; Florido J; Martínez-Ruiz L; García-López S; Adan C; Rodríguez-Santana C; Acuña-Castroviejo D; Quiñones-Hinojosa A; Fernández-Martínez J; Abdel Moneim AE; López LC; Rodríguez Ferrer JM; Escames G
Oxid Med Cell Longev; 2019; 2019():7187128. PubMed ID: 30944696
[TBL] [Abstract][Full Text] [Related]
3. Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation.
Shen YQ; Guerra-Librero A; Fernandez-Gil BI; Florido J; García-López S; Martinez-Ruiz L; Mendivil-Perez M; Soto-Mercado V; Acuña-Castroviejo D; Ortega-Arellano H; Carriel V; Diaz-Casado ME; Reiter RJ; Rusanova I; Nieto A; López LC; Escames G
J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29247557
[TBL] [Abstract][Full Text] [Related]
4. Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport.
Florido J; Martinez-Ruiz L; Rodriguez-Santana C; López-Rodríguez A; Hidalgo-Gutiérrez A; Cottet-Rousselle C; Lamarche F; Schlattner U; Guerra-Librero A; Aranda-Martínez P; Acuña-Castroviejo D; López LC; Escames G
J Pineal Res; 2022 Oct; 73(3):e12824. PubMed ID: 35986493
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between Clock Genes, Sirtuin 1, and Mitochondrial Activity in Head and Neck Squamous Cell Cancer: Effects of Melatonin Treatment.
Rodríguez-Santana C; López-Rodríguez A; Martinez-Ruiz L; Florido J; Cela O; Capitanio N; Ramírez-Casas Y; Acuña-Castroviejo D; Escames G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834478
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS.
Wang L; Wang C; Li X; Tao Z; Zhu W; Su Y; Choi WS
Cell Mol Biol Lett; 2023 May; 28(1):36. PubMed ID: 37131152
[TBL] [Abstract][Full Text] [Related]
7. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
8. The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Hagege A; Ambrosetti D; Boyer J; Bozec A; Doyen J; Chamorey E; He X; Bourget I; Rousset J; Saada E; Rastoin O; Parola J; Luciano F; Cao Y; Pagès G; Dufies M
Theranostics; 2021; 11(19):9571-9586. PubMed ID: 34646387
[No Abstract] [Full Text] [Related]
9. Melatonin and verteporfin synergistically suppress the growth and stemness of head and neck squamous cell carcinoma through the regulation of mitochondrial dynamics.
Shin YY; Seo Y; Oh SJ; Ahn JS; Song MH; Kang MJ; Oh JM; Lee D; Kim YH; Sung ES; Kim HS
J Pineal Res; 2022 Jan; 72(1):e12779. PubMed ID: 34826168
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function.
Guerra-Librero A; Fernandez-Gil BI; Florido J; Martinez-Ruiz L; Rodríguez-Santana C; Shen YQ; García-Verdugo JM; López-Rodríguez A; Rusanova I; Quiñones-Hinojosa A; Acuña-Castroviejo D; Marruecos J; De Haro T; Escames G
Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33919790
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.
Duvillard C; Romanet P; Cosmidis A; Beaudouin N; Chauffert B
Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):229-33. PubMed ID: 15053208
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
[TBL] [Abstract][Full Text] [Related]
15. Melatonin inhibits EMT and PD-L1 expression through the ERK1/2/FOSL1 pathway and regulates anti-tumor immunity in HNSCC.
Luo X; Chen Y; Tang H; Wang H; Jiang E; Shao Z; Liu K; Zhou X; Shang Z
Cancer Sci; 2022 Jul; 113(7):2232-2245. PubMed ID: 35298069
[TBL] [Abstract][Full Text] [Related]
16. VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells.
Chen T; Yang F; Dai X; Yu Y; Sun Y; Wu X; Li R; Zhou Q
Curr Cancer Drug Targets; 2023; 23(6):482-495. PubMed ID: 36748213
[TBL] [Abstract][Full Text] [Related]
17. Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.
Gu Z; Shi C; Li J; Han Y; Sun B; Zhang W; Wu J; Zhou G; Ye W; Li J; Zhang Z; Zhou R
BMC Med; 2022 May; 20(1):175. PubMed ID: 35546399
[TBL] [Abstract][Full Text] [Related]
18. Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Head and Neck Cancer Xenografts.
Rowan BG; Lacayo EA; Sheng M; Anbalagan M; Gimble JM; Jones RK; Joseph WJ; Friedlander PL; Chiu ES
Aesthet Surg J; 2016 Jan; 36(1):93-104. PubMed ID: 26063833
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin.
Catalán M; Rodríguez C; Olmedo I; Carrasco-Rojas J; Rojas D; Molina-Berríos A; Díaz-Dosque M; Jara JA
Adv Exp Med Biol; 2021; 1326():95-109. PubMed ID: 33368015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
